You have 9 free searches left this month | for more free features.

Condition

Contrast Induced Nephropathy (1)

Coronary Artery Disease (1)

Coronary Artery Disease (CAD) (1)

Coronary Microvascular Disease (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Astellas Pharma Inc (1)

Cedars-Sinai Medical Center (1)

Sun Yat-sen University (1)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI) (1)

Intervention

contrast (3)

multidetector computed tomography (1)

myocardial perfusion cardiac mri. (1)

pharmacologic stress agent (1)

regadenoson (1)

single photon emission computed tomography (1)

technetium tc99m sestamibi /technetium tc99m tetrafosmin (1)

Study Documents

Intervention Type

drug (3)

device (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

contrast

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Whole-Heart Myocardial Blood Flow Quantification Using MRI

Recruiting

Coronary Artery Disease
Coronary Microvascular Disease

Myocardial Perfusion Cardiac MRI.
+2 more

Los Angeles, California

Cedars-Sinai Medical Center

Jan 25, 2021

Coronary Artery Disease (CAD) Trial in United States (drug, radiation, procedure)

Completed

Has Results

Coronary Artery Disease (CAD)

regadenoson
+4 more

Roseville, California
+10 more

Nov 21, 2017

Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial

Completed

Contrast Induced Nephropathy

contrast

Guangzhou, Guangdong, China

Xiaodong Zhaung

Jan 6, 2016